Journal decision profile

Pharmaceutical Medicine

Medicine · Pharmacology, Toxicology and Pharmaceutics

Pharmaceutical Medicine's 2026 Journal Metrics Score is 1.1, ranking Q3 in Economics and Econometrics and 1 other subfield. Two-year citation average from OpenAlex data, updated August 2026.

Adis, Springer HealthcareSwitzerlandpISSN 1178-2595eISSN 1179-1993
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
1.1

Journal Metrics Score 2026 · 2021–2024 window citedness 4.49.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED

Not available — there are not enough recent PubMed records with both received and accepted dates.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$4,290

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

Free preview · no sign-in

Does your manuscript fit Pharmaceutical Medicine?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
1.12026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#150 / 680LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
23.8%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
1.30MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
—NOT AVAILABLE
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
43 / yr2021–2024 AVG
Field-normalized top 10% share23.8%

41 of 172 works · same type, year & subfield

Field-normalized top 1% share2.9%

5 works · same type, year & subfield

Median FWCI1.30×

Above field-year expectation

Source output rank#150

of 680 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.30, so its typical recent paper runs about 30% above its field benchmark.

What does Top 10% Share mean?

23.8% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

452016
442017
412018
572019
492020
432021
392022
532023
372024
2352025

Recent work-type mix

172 OpenAlex works · 2021–2024

Article91.9%
Review4.1%
Erratum1.7%
Paratext1.7%
Letter0.6%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much Pharmaceutical Medicine publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
Pharmacovigilance and Adverse Drug Reactions25
Pharmaceutical Economics and Policy22
Pharmaceutical industry and healthcare12
Biosimilars and Bioanalytical Methods5
Biomedical Ethics and Regulation4
Ethics in Clinical Research4
Healthcare Regulation4
Mental Health and Patient Involvement4
Pharmaceutical studies and practices4
Artificial Intelligence in Healthcare and Education3
Methodology: OpenAlex snapshot 2026-10-19. FWCI, percentile badges, topics, and type mix use 172 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Economics and EconometricsQ3
Pediatrics, Perinatology and Child HealthQ3
ToxicologyQ4
Q3
Subfield Quartile
N/A
CAS Block

Ranking and source check

#4,308
of 6,272 Medicine field journals
#635
among Q3 Medicine journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
1,207
H-Index
37
Fully Open Access
No
Recent OA Works
241
Subject Areas
Economics and EconometricsPediatrics, Perinatology and Child HealthToxicology

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

Common questions about Pharmaceutical Medicine

What is Pharmaceutical Medicine's Journal Metrics Score in 2026?

Pharmaceutical Medicine's 2026 Journal Metrics Score is 1.1, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What quartile is Pharmaceutical Medicine in?

Pharmaceutical Medicine's best quartile is Q3. By OpenAlex subfield: Q3 in Economics and Econometrics; Q3 in Pediatrics, Perinatology and Child Health; Q4 in Toxicology. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Pharmaceutical Medicine will not match this score exactly. Compare journals using one source at a time.

How much does it cost to publish in Pharmaceutical Medicine?

OpenAlex lists an indicative article processing charge of $4,290 USD for Pharmaceutical Medicine. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.

Which journals are alternatives to Pharmaceutical Medicine?

Comparable journals include Therapeutic Innovation & Regulatory Science, International Journal of Risk & Safety in Medicine, Journal of Pharmacy and Pharmaceutical Sciences, and Journal of Pharmaceutical Policy and Practice. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

Back to Search